Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective Study From The Campus All/Gimema Network

NCT03803670 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT03803670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03803670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective Study From The Campus All/Gimema Network
Lead sponsor
University of Rome Tor Vergata
Phase
Observational
Overall status
Completed
Start date
January 1, 2007
Completion date
January 10, 2019
Enrollment
241 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia